Trevi revs up extended-release opioid cough program, exiting phase 2 early and racing into next stage ssorensen Mon, […]

COPD Foundation links arms with Ena on antiviral nasal spray ahead of phase 2 trials in COVID-19, flu […]

Editor’s Corner: Fierce Pharma gets a fierce makeover esagonowsky Fri, 02/25/2022 – 09:38

Recently published research determined that the Epic Systems Corporation Sepsis Model—a widely implemented electronic health record (EHR) based […]

Unmet need among over 7000 rare diseases is being addressed in a comprehensive action plan

Quviviq can be used on a long-term basis, addressing a key limitation of existing therapies

Lexicon pulls FDA submission for sotagliflozin to fix ‘technical issue,’ plans prompt refiling esagonowsky Mon, 02/28/2022 – 10:34

Sanofi chases fourth Dupixent nod after late-stage eosinophilic esophagitis trial win fkansteiner Mon, 02/28/2022 – 10:52

Extract from the bark of the Neem tree may help treat and reduce the spread of coronavirus, according […]

‘Light up for Rare’ spotlights rare disease to help break the isolation COVID has wrought badams Mon, 02/28/2022 […]